391
Views
21
CrossRef citations to date
0
Altmetric
Review Article

The Angiopoietin ligands and Tie receptors: potential diagnostic biomarkers of vascular disease

& ORCID Icon
Pages 187-193 | Received 03 Apr 2019, Accepted 19 Jul 2019, Published online: 20 Aug 2019
 

Abstract

The Angiopoietin-1 (Angpt1)/Tie2 signaling pathway is important in regulating vascular function. Angpt1-induced Tie2 activation promotes vascular endothelial cell survival and reduces vascular leakage. Angiopoietin-2 (Angpt2), a weak agonist/antagonist of Tie2, opposes and regulates Angpt1 action. The Tie family of receptor tyrosine kinases, Tie2 and Tie1, exist as either homo-or heterodimers. The molecular complex between the receptors is also crucial in controlling Angpt1 signaling; hence, the molecular balance between Angpt1:Angpt2 and Tie2:Tie1 is important in determining endothelial integrity and vascular stability. This review presents evidence of the change observed in the Angiopoietin/Tie molecules in various pathophysiological conditions and discusses the potential clinical applications of these molecules in vascular complications.

Acknowledgements

The authors thank Prof NPJ Brindle for advice over the years in the area of Angiopoietin signaling.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by DMU PhD scholarship 2016 [grant number HLS FB1].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.